Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic merkel cell carcinoma (mMCC) progressed on chemotherapy Meeting Abstract
| Authors: | van Hagen, T.; Sandhu, S.; Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbe, C.; Lewis, K. D.; Linette, G. P.; Milella, M.; Hennessy, M.; Bajars, M.; Hicking, C.; D'Angelo, S. P. |
| Abstract Title: | Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic merkel cell carcinoma (mMCC) progressed on chemotherapy |
| Meeting Title: | 45th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 14 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2018 Nov 13-15 |
| Meeting Location: | Perth, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2018-11-01 |
| Start Page: | 172 |
| End Page: | 173 |
| Language: | English |
| ACCESSION: | WOS:000449544200293 |
| PROVIDER: | wos |
| PUBMED: | 30375725 |
| DOI: | 10.1111/ajco.13089 |
| Notes: | Meeting Abstract: 364 -- Source: Wos |
